GENinCode Plc announced its intention to appoint Professor Huon Gray CBE, to the Board as an independent non-executive director. Huon served as the National Clinical Director for Heart Disease in the Department of Health and then NHS England from 2012-2019, advising government, all party parliamentary groups, the NHS and NICE on healthcare delivery and reform. Huon will be appointed to the board of GENinCode following finalisation of the terms of his appointment and the completion of the necessary regulatory due diligence in accordance with the AIM Rules.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.375 GBX | +4.08% | -17.74% | +21.43% |
06-04 | Transcript : GENinCode Plc, 2023 Earnings Call, Jun 04, 2024 | |
06-03 | GENinCode revenue grows amid continued international expansion | AN |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+21.43% | 13.86M | |
-6.76% | 12.28B | |
-5.12% | 8.05B | |
+8.91% | 5.84B | |
+29.23% | 5.66B | |
-15.84% | 3.99B | |
+12.16% | 2.7B | |
-60.53% | 2.7B | |
-6.99% | 2.39B | |
+16.25% | 2.02B |
- Stock Market
- Equities
- GENI Stock
- News GENinCode Plc
- GENinCode plc to Appoint Huon Gray to the Board as an Independent Non-executive Director